Cultural Industries Telethon Kids Institute to lead COVID-19 drug trial Telethon Kids Institute has received $2.66 million from BHP to lead a trial testing the effectiveness of multiple sclerosis drug interferon in reducing the infectiousness of COVID-19 patients. 06 May 2020
